JS
Joshua Savage
Also known as: Josh Savage, Joshua S Savage, J S Savage
University of Birmingham
Research areas: Medicine · Urology · Sexual function and dysfunction studies · Urological Disorders and Treatments · Dupuytren's Contracture and Treatments
0000-0003-0599-0245
Employment
-
Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Trial Management Team Leader2018 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (31)
- Ceralasertib plus Durvalumab in Ras Mutant and Ras Wild-Type Advanced Non–Small Cell Lung Cancer: Two Cohorts of the Phase II Platform National Lung Matrix Trial Save
- Responses can be achieved with a combination of the MEK inhibitor selumetinib and dexamethasone in patients with relapsed/refractory RAS-pathway mutated acute lymphoblastic leukemia: Results of a parallel cohort, dose-finding and expansion phase I/II tri… Save
- Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a … Save
- Interpreting results from biomarker-guided clinical trials: avoiding “negative” or “failed” terminology Save
- Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART) Save
- A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer Save
- Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer Save
- A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT) Save
- Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information Save
- Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units. Save
- Protocol for the Tessa Jowell BRAIN MATRIX Platform Study Save
- Clinical trial management Save
- Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phas… Save
- CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults Save
- Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2) Save
- The National Lung Matrix Trial of personalized therapy in lung cancer Save
- Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol Save
- Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): Results of the PePS2 trial Save
- Identification of roles for the SNARE-associated protein, SNAP29, in mouse platelets Save
- UKMCC-01: A phase II study of pazopanib (PAZ) in metastatic Merkel cell carcinoma. Save